These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26044421)

  • 41. Genome Sequences of Two Pseudomonas aeruginosa Isolates with Defects in Type III Secretion System Gene Expression from a Chronic Ankle Wound Infection.
    Karash S; Nordell R; Ozer EA; Yahr TL
    Microbiol Spectr; 2021 Sep; 9(1):e0034021. PubMed ID: 34259549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
    Agyeman AA; López-Causapé C; Rogers KE; Lucas DD; Cortés-Lara S; Gomis-Font MA; Fraile-Ribot P; Figuerola J; Lang Y; Franklyn ERT; Lee WL; Zhou J; Zhang Y; Bulitta JB; Boyce JD; Nation RL; Oliver A; Landersdorfer CB
    Int J Antimicrob Agents; 2023 Sep; 62(3):106887. PubMed ID: 37315906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic scan of a healthcare-associated NDM-1-producing Citrobacter freundii ST18 isolated from a green sea turtle impacted by plastic pollution.
    Aravena-Ramírez V; Fuentes-Castillo D; Vilaça ST; Goldberg DW; Esposito F; Silva-Pereira TT; Fontana H; Sellera FP; Lincopan N
    J Glob Antimicrob Resist; 2024 Mar; 36():389-392. PubMed ID: 38266960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Diversity, Multidrug Resistance, and Virulence of
    Liu L; Chen D; Liu L; Lan R; Hao S; Jin W; Sun H; Wang Y; Liang Y; Xu J
    Front Cell Infect Microbiol; 2018; 8():233. PubMed ID: 30050870
    [No Abstract]   [Full Text] [Related]  

  • 45. Complete-genome sequencing and comparative genomic characterization of bla
    Ye J; Jin L; Li Y; Xu H; Lin Y; Zhou T; Zheng B; Wang M; Wang Z
    BMC Genomics; 2023 Aug; 24(1):506. PubMed ID: 37649002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid.
    Villa J; Arana DM; Viedma E; Perez-Montarelo D; Chaves F
    Int J Med Microbiol; 2017 Sep; 307(6):340-345. PubMed ID: 28711315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole genome sequencing of resistance and virulence genes in multi-drug resistant Pseudomonas aeruginosa.
    Almaghrabi RS; Macori G; Sheridan F; McCarthy SC; Floss-Jones A; Fanning S; Althawadi S; Mutabagani M; Binsaslloum A; Alrasheed M; Almohaizeie A; Allehyani B; Alghofaili A; Bohol MF; Al-Qahtani AA
    J Infect Public Health; 2024 Feb; 17(2):299-307. PubMed ID: 38154433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.
    Head NE; Yu H
    Infect Immun; 2004 Jan; 72(1):133-44. PubMed ID: 14688090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic Diversity, Biofilm Formation, and Antibiotic Resistance of
    Mahmoud SF; Fayez M; Swelum AA; Alswat AS; Alkafafy M; Alzahrani OM; Alsunaini SJ; Almuslem A; Al Amer AS; Yusuf S
    Vet Sci; 2022 May; 9(5):. PubMed ID: 35622767
    [No Abstract]   [Full Text] [Related]  

  • 50. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
    Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP
    J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa.
    Abdelghafar A; El-Ganiny A; Shaker G; Askoura M
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1207-1234. PubMed ID: 37608144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic Resistance Pattern and Distribution of pslA Gene Among Biofilm Producing Pseudomonas aeruginosa Isolated From Waste Water of a Burn Center.
    Emami S; Nikokar I; Ghasemi Y; Ebrahimpour M; Sedigh Ebrahim-Saraie H; Araghian A; Faezi S; Farahbakhsh M; Rajabi A
    Jundishapur J Microbiol; 2015 Nov; 8(11):e23669. PubMed ID: 26855739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First detection and genomics analysis of KPC-2-producing Citrobacter isolates from river sediments.
    Xu H; Wang X; Yu X; Zhang J; Guo L; Huang C; Jiang X; Li X; Feng Y; Zheng B
    Environ Pollut; 2018 Apr; 235():931-937. PubMed ID: 29358148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analyses of a Ceftazidime-Avibactam-Resistant
    Castanheira M; Arends SJR; Davis AP; Woosley LN; Bhalodi AA; MacVane SH
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30258039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic characterisation of a complex class 1 integron in an NDM-1-producing Citrobacter freundii ST396 clinical strain isolated from a urine sample.
    Li Z; Lin Y; Lu L; Wang K; Yang L; Li P; Li J; Jia L; Li P; Song H
    J Glob Antimicrob Resist; 2020 Dec; 23():64-66. PubMed ID: 32818668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Characterization of
    Wang L; Li Z; Xiao N; Tang J; He Y; Guo J; Zhao X
    Infect Drug Resist; 2022; 15():2235-2242. PubMed ID: 35510156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic characterization of a novel sequence type of multidrug-resistant
    Jiang X; Cui X; Liu W; Xu H; Zheng B
    Infect Drug Resist; 2019; 12():2775-2779. PubMed ID: 31564927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran.
    Azimi S; Kafil HS; Baghi HB; Shokrian S; Najaf K; Asgharzadeh M; Yousefi M; Shahrivar F; Aghazadeh M
    GMS Hyg Infect Control; 2016; 11():Doc04. PubMed ID: 26958458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates.
    Oliveira H; Pinto G; Oliveira A; Oliveira C; Faustino MA; Briers Y; Domingues L; Azeredo J
    Appl Microbiol Biotechnol; 2016 Dec; 100(24):10543-10553. PubMed ID: 27683211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of MALDI-TOF mass spectrometry to detect nosocomial outbreaks of Serratia marcescens and Citrobacter freundii.
    Rödel J; Mellmann A; Stein C; Alexi M; Kipp F; Edel B; Dawczynski K; Brandt C; Seidel L; Pfister W; Löffler B; Straube E
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):581-591. PubMed ID: 30680577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.